Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Androgens, like testosterone, are crucial for early testicular descent in rats.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Clascoterone cream could be used for other skin conditions affected by hormones.

Hirsutism is abnormal male-pattern hair growth in females due to excess androgens.

Different substances affect hair and skin cell growth in various ways.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

A new compound was made that might help treat diseases related to male hormones.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Medical treatments can help manage frontal fibrosing alopecia, but hair transplantation should be done cautiously and only if the disease is inactive.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Female pattern alopecia is common, starts in late 20s, and is not androgen dependent.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.